» Articles » PMID: 12534310

Effect of Reproductive Hormones and Selective Estrogen Receptor Modulators on Mood During Menopause

Overview
Journal Drugs Aging
Specialties Geriatrics
Pharmacology
Date 2003 Jan 22
PMID 12534310
Citations 19
Authors
Affiliations
Soon will be listed here.
Abstract

Periods of intense hormonal fluctuations have been associated with heightened prevalence and exacerbation of underlying psychiatric illness, particularly the occurrence of premenstrual dysphoria, puerperal depression and depressive symptoms during perimenopause. It has been speculated that sex steroids such as estrogens, progestogens, testosterone and dehydroepiandrosterone (DHEA) exert a significant modulation of brain functioning, possibly through interactions with various neurotransmitter systems. It is therefore intuitive that abrupt alterations of these hormones would interfere with mood and behaviour. On the other hand, accumulating data suggest that hormonal interventions may also promote relief or even remission of depressive symptoms, as already demonstrated in studies with patients experiencing postpartum depression and perimenopausal depressive disorders. The extent to which perimenopause, alone, may increase the risk for depression is unclear. However, existing data strongly suggest that some women are particularly vulnerable to developing significant physical and psychological disturbances when entering perimenopause. This article reviews the effect of sex hormones and selective estrogen receptor modulators (SERMs) on mood among peri- and postmenopausal women. There are preliminary, though promising, data on the use of estradiol (particularly transdermal estradiol) to alleviate depression during perimenopause, use of a combination of estrogens and selective serotonin reuptake inhibitors for depression during the postmenopausal period, and the use of testosterone to improve psychological well-being and increase libido among women with induced menopause. Further studies would help to better delineate the usage of hormones as an antidepressant strategy (monotherapy or augmenting treatment) for peri- and postmenopausal women. A brief review of some nonhormonal interventions for the treatment of menopause-related symptoms that may significantly affect a woman's quality of life is also presented. There are some preliminary data suggesting the efficacy of antidepressants for the treatment of hot flushes; existing data on diet supplements and herbal products have shown more mixed results.

Citing Articles

Migraine and Irritable Bowel Syndrome Among the General Population in Aseer Region.

Alhammadi N, Bedywi R, Shawkhan R, Aljari A, Asiri S, Al Hamdan J Cureus. 2023; 15(9):e45047.

PMID: 37829989 PMC: 10566572. DOI: 10.7759/cureus.45047.


Neuroendocrine pathogenesis of perimenopausal depression.

Han Y, Gu S, Li Y, Qian X, Wang F, Huang J Front Psychiatry. 2023; 14:1162501.

PMID: 37065890 PMC: 10098367. DOI: 10.3389/fpsyt.2023.1162501.


Prevalence and comorbidity of migraine headache: results from the Singapore Mental Health Study 2016.

Jeyagurunathan A, Abdin E, Vaingankar J, Chua B, Shafie S, Chang S Soc Psychiatry Psychiatr Epidemiol. 2019; 55(1):33-43.

PMID: 31456029 DOI: 10.1007/s00127-019-01755-1.


Effects of Sex Steroids in the Human Brain.

Nguyen T, Ducharme S, Karama S Mol Neurobiol. 2016; 54(9):7507-7519.

PMID: 27822715 DOI: 10.1007/s12035-016-0198-3.


Ovarian steroids increase PSD-95 expression and dendritic spines in the dorsal raphe of ovariectomized macaques.

Rivera H, Bethea C Synapse. 2013; 67(12):897-908.

PMID: 23959764 PMC: 3975919. DOI: 10.1002/syn.21702.


References
1.
George G, Utian W, Beaumont P, Beardwood C . Effect of exogenous oestrogens on minor psychiatric symptoms in postmenopausal women. S Afr Med J. 1973; 47(49):2387-8. View

2.
Wolf O, Kirschbaum C . Actions of dehydroepiandrosterone and its sulfate in the central nervous system: effects on cognition and emotion in animals and humans. Brain Res Brain Res Rev. 1999; 30(3):264-88. DOI: 10.1016/s0165-0173(99)00021-1. View

3.
Yaffe K, Ettinger B, Pressman A, Seeley D, Whooley M, Schaefer C . Neuropsychiatric function and dehydroepiandrosterone sulfate in elderly women: a prospective study. Biol Psychiatry. 1998; 43(9):694-700. DOI: 10.1016/s0006-3223(97)00303-x. View

4.
Amsterdam J, Fawcett J, Quitkin F, Reimherr F, Rosenbaum J, Beasley C . Fluoxetine efficacy in menopausal women with and without estrogen replacement. J Affect Disord. 1999; 55(1):11-7. DOI: 10.1016/s0165-0327(98)00203-1. View

5.
Waldinger M, Berendsen H, Schweitzer D . Treatment of hot flushes with mirtazapine: four case reports. Maturitas. 2000; 36(3):165-8. DOI: 10.1016/s0378-5122(00)00152-3. View